ライフサイエンスコーパス: perfusion scintigraphy

1 ts of greater perfusion defect on myocardial perfusion scintigraphy.

2 ine SR showed good agreement with myocardial perfusion scintigraphy.

3 cal atherosclerotic disease using myocardial perfusion scintigraphy.

4 pulmonary embolism, supplanting ventilation/perfusion scintigraphy.

5 as a new stress modality in combination with perfusion scintigraphy.

6 19 who underwent CT pulmonary angiography or perfusion scintigraphy.

7 n extracted from adenosine stress myocardial perfusion scintigraphy, a commonly performed test, is of

8 or cost-effective applications of myocardial perfusion scintigraphy, a large amount of research has r

9 butamine stress echocardiography, myocardial perfusion scintigraphy and dipyridamole stress testing c

10 er, its accuracy in comparison to myocardial perfusion scintigraphy and to that of high dose DE remai

11 Conventional perfusion scintigraphy assesses disparities in regional

12 accuracy similar to both CTA and ventilation-perfusion scintigraphy, at lower cost and with lower rad

13 Perfusion scintigraphy can provide modest prognostic inf

14 Perfusion scintigraphy combined with chest radiography c

15 is diameter 55%+/-11%), underwent myocardial perfusion scintigraphy for documentation of reversible p

16 echocardiography may be more versatile than perfusion scintigraphy for identifying the presence and

17 Although ventilation/perfusion scintigraphy has been supplanted by computed t

18 ch as stress echocardiography and myocardial perfusion scintigraphy have limited accuracy, and newer

19 , semiautomated CT densitometry, and (99m)Tc perfusion scintigraphy in 28 patients being evaluated fo

20 We sought to study the accuracy of exercise perfusion scintigraphy in patients with an implanted api

21 The specificity of exercise perfusion scintigraphy is decreased in patients with a l

22 Although myocardial perfusion scintigraphy is of proven value in the risk st

23 risk estimates from 256-slice CTPA and lung perfusion scintigraphy (LPS) for comparison.

24 Conclusion: Perfusion scintigraphy may be useful to follow patients

25 omprehensive echocardiogram and a myocardial perfusion scintigraphy (MPS) at inclusion.

26 sess the clinical value of stress myocardial perfusion scintigraphy (MPS) in elderly patients (> or =

27 xtent and severity of ischemia on myocardial perfusion scintigraphy (MPS) is commonly used to risk-st

28 ssive and recurring; thus, stress myocardial perfusion scintigraphy (MPS) is widely used to identify

29 Myocardial perfusion scintigraphy (MPS) was used to assess adenosin

30 Compared with stress myocardial perfusion scintigraphy (MPS), CCTA was associated with a

31 Whether abnormal myocardial perfusion scintigraphy (MPS), dobutamine stress echocard

32 rmine appropriateness ratings for myocardial perfusion scintigraphy (MPS), stress echocardiography (S

33 lcium (CAC) scanning and exercise myocardial perfusion scintigraphy (MPS).

34 value for myocardial ischemia on myocardial perfusion scintigraphy of all parameters was compared us

35 o reduction in ischemic burden on myocardial perfusion scintigraphy or in the safety endpoints of maj

36 went lower-extremity ultrasound, ventilation-perfusion scintigraphy, or both, followed by pulmonary C

37 ventional pulmonary angiography, ventilation-perfusion scintigraphy, or lower-extremity ultrasonograp

38 s with left bundle branch block referred for perfusion scintigraphy over a 5-year span.

39 Gated myocardial perfusion scintigraphy permits simultaneous assessment o

40 Myocardial contractile reserve and resting perfusion scintigraphy provide independent information t

41 ing method (SC) or 2-dimensional planar lung perfusion scintigraphy (PS).

42 method (SC) or a two-dimensional planar lung perfusion scintigraphy (PS).

43 onal flow reserve (FFR) compared with stress perfusion scintigraphy (SPS) in patients with recent uns

44 99m)Tc-macroaggregated albumin ((99m)Tc-MAA) perfusion scintigraphy to estimate the liver-to-lung shu

45 ical practice catheter cerebral angiography, perfusion scintigraphy, transcranial Doppler sonography,

46 Perfusion scintigraphy using (99m)Tc-labeled albumin agg

47 PE found at CT pulmonary angiography and perfusion scintigraphy was correlated with clinical and

48 or rule out CTEPH should include ventilation-perfusion scintigraphy, which has high sensitivity and a

49 tients underwent angiographic assessment and perfusion scintigraphy with (99m)Tc-MAA before lobar (90

50 g for carbon monoxide (DLCO), Tc99m-MAA lung perfusion scintigraphy with PS and SPECT/CT quantificati